EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mechanisms and therapeutic potential of glycyrrhizic acid: Insights into key signaling pathways and disease modulation (Review)

Jinjin Yu, Huiheng Qu, Weicheng Xu, Yiming Fang, Nan Wang, Wei Shi

Molecular Medicine Reports · 04.03.2026 · 33 (5) · 1-13

DOI: 10.3892/mmr.2026.13836 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 04.03.2026. Verfasst von Jinjin Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu 214000, P.R. China. Hauptthemen laut MEDLINE: Glycyrrhizic Acid, Signal Transduction, Anti-Inflammatory Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycyrrhizic acid (GL), a natural extract derived from licorice, has shown notable therapeutic potential across various diseases through complex mechanisms involving key signaling pathways. The present review systematically summarized the primary biological actions of GL, highlighting its role as an inhibitor of high‑mobility group box‑1 and regulator of multiple notable pathways, including the nuclear factor‑κB, phosphoinositide 3‑kinase/protein kinase B, mitogen‑activated protein kinase, Janus kinase/signal transducer and activator of transcription and pyroptosis‑related pathways. GL effectively modulates innate and adaptive immune responses, reduces inflammation and exhibits protective effects against liver injury. In oncology, GL has demonstrated anti‑proliferative and pro‑apoptotic effects by interacting with the tumor microenvironment, suppressing angiogenesis and enhancing chemotherapeutic efficacy as an adjuvant therapy. By synthesizing previous research advancements that elucidate the multifaceted biological mechanisms of GL, the present review aimed to provide a comprehensive foundation for future translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhizic AcidSignal TransductionAnti-Inflammatory AgentsHumansAnimalsHMGB1 ProteinNF-kappa B

Stichwörter der Autor:innen

HMGB1glycyrrhizic acidinflammationsignaling pathways

Substanzen

Glycyrrhizic AcidHMGB1 ProteinAnti-Inflammatory AgentsNF-kappa B

Autor:innen und Institutionen

  • Department of Ophthalmology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu 214000, P.R. China.
  • Department of General Surgery, Jiangnan University Medical Center, Jiangnan University, Wuxi, Jiangsu 214002, P.R. China.
  • Department of Ophthalmology, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine, The First Clinical Medical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210004, P.R. China.
  • Department of Cancer Biology, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston‑Salem, NC 27157, USA.

Zitieren

APA

Yu, J., Qu, H., Xu, W., Fang, Y., Wang, N., & Shi, W. (2026). Mechanisms and therapeutic potential of glycyrrhizic acid: Insights into key signaling pathways and disease modulation (Review). Molecular Medicine Reports, 33(5), 1-13. https://doi.org/10.3892/mmr.2026.13836

Vancouver

Yu J, Qu H, Xu W, Fang Y, Wang N, Shi W. Mechanisms and therapeutic potential of glycyrrhizic acid: Insights into key signaling pathways and disease modulation (Review). Molecular Medicine Reports. 2026;33(5):1-13. doi:10.3892/mmr.2026.13836

BibTeX
@article{Yu2026,
  author = {Yu, Jinjin and Qu, Huiheng and Xu, Weicheng and Fang, Yiming and Wang, Nan and Shi, Wei},
  title = {Mechanisms and therapeutic potential of glycyrrhizic acid: Insights into key signaling pathways and disease modulation (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  volume = {33},
  number = {5},
  pages = {1--13},
  doi = {10.3892/mmr.2026.13836}
}
Kostenlos starten →